Recursion Pharmaceuticals
As a Principal at the Boston Consulting Group's San Francisco office, Matt advised biopharma and tech clients on a broad range of strategic decisions including portfolio optimization, product launch forecasting and M&A. Prior to that, he also worked at the UBS Investment Bank in New York and supported M&A and capital market transactions across industries.
Matt completed his undergraduate degrees in finance and economics at the University of Virginia's McIntire School of Commerce and earned his MBA at Northwestern University's Kellogg School of Management. When not at work, he can be found trail running, cross country skiing and spending time with his family.
This person is not in any offices
Recursion Pharmaceuticals
13 followers
Recursion is a clinical-stage biotechnology company combining experimental biology and automation with artificial intelligence in a massively parallel system to efficiently discover potential drugs for diverse indications, including genetic disease, inflammation, immunology, and infectious disease.